Proximie secures £ 66.75 million investment in Series C led by Advent Life Sciences – UK technology investment news

London – June 14, 2022 – Nextthe global healthcare technology platform that connects digitally
operating theaters (OR) announces it has successfully raised $ 80 million in Series C equity
financing. The investment follows a year in which Proximie saw a significant increase in its Total
Contracted Value, has supported over 13,000 surgeries and expanded its global presence to 100

The funding round was led by Advent Life Sciences, a leading transatlantic initiative
investors building innovative life science businesses, with the participation of new investors
Emerson Collective – the impact investor founded by Laurene Powell Jobs, SoftBank Vision Fund
2, British Patient Capital, Mubadala Investment Company and Minderoo Foundation.
Existing Investors F-Prime Capital, Eight Roads, This Capital, Global Ventures and Maverick
Businesses also participated in the round.

The proceeds will be used to accelerate the development of key products and services to be built
Proximie’s market ecosystem is scaling your own operating room operating system: a centralized system
platform that provides related surgical care. Leverage hospitals and surgical centers
Proximie’s technology will have access to preoperative data that can help inform patient care,
collaborative real-time tools to record, train and deliver post-operative care and content
management tools to acquire and distribute content to one’s colleagues. Taken together,
Proximie will enable healthcare systems to establish an intelligent digital level for the operating room, enabling
them to save time, money and more lives.

Proximie has been used for surgical specialty cases in over 500 hospitals around the world.
Hospitals have applied Proximie technology to increase efficiency in the surgical backlog
in the aftermath of COVID-19, it increased the speed of surgeon training while keeping costs and built
hub and spoke models that concentrate surgical care and skills in central positions to be reduced
the time and costs associated with the trip.

Dr Nadine Hachach-Haram, CEO and founder of Proximie, said:

“Our vision is to democratize surgery through better data by connecting every operating room and cath lab in the world. We began this journey by allowing surgeons to enter virtually any operating room. We are now using this capability to digitize the OR, offering patients the collective experience of the world’s best surgeons, where data collected and shared on Proximie can help them receive life-saving care, no matter where they live. “

Five billion people currently lack access to safe surgery, with over 18 million people dying each
year from the lack of access to surgery. Launched in 2016, Proximie is a tool that allows surgeons to do this
virtually “scrub in” into any operating room in the world, extending the capabilities of top
surgeons in areas without access to the best surgical care. With the inhibition of the COVID-19 pandemic
travel and access, Proximie has grown rapidly, scaling across five continents and over 100 countries,
help surgeons provide life-saving care during a period of health care interruption.

Dr. Shahzad Malik, General Partner Advent Life Sciences, said:

“We are delighted to partner with Proximie and a group of world-class investors as the company expands its global presence and product capabilities. The company fits perfectly with our philosophy of supporting the best innovative companies in the life sciences that have the ability to positively impact human health and healthcare delivery in paradigm-changing ways. “
Successful completion of today’s fundraiser means Proximie has raised a total of $ 130 million since the beginning.

John Cassidy, Investment Director of SoftBank Investment Advisers, said:

“The pandemic has rapidly accelerated the adoption of virtual clinical care globally. proximity
the technological platform combines artificial intelligence, machine learning and augmented reality to facilitate live
sharing the operating room, creating a connected surgical care ecosystem for better support
patients and hospitals. We are delighted to partner with Dr. Nadine Hachach-Haram and the
The Proximie team to support their mission to save lives by sharing the best clinic in the world
practices “.

Further information
Jamie Pudge
[email protected]
+44 7557 771 703

Notes to editors

About Proximity
● Proximie is a global healthcare technology platform focused on operational and digitalization
diagnostic rooms;
● Proximie’s mission is to provide a connected surgical platform to help deliver quality surgery
care around the world. Each Proximie procedure can be recorded, analyzed and exploited
for future use to help inform on best practices;
● By connecting ORs globally, Proximie is facilitating a rich and in-depth data set
which naturally feeds best practices across the entire healthcare ecosystem;
● Founded by Dr Nadine Hachach-Haram, Proximie has currently run tens of thousands
surgical procedures and has been distributed in over 500 hospitals in 100 countries in five
● Proximie has contracts with over 35 major medical device companies, with access to 90%
of operating theaters and diagnostic suites in the UK, US and EU – and was published in
over 20 medical journals;
● For more information, visit or follow @ProximieAR on Twitter.

Speaking of Advent Life Sciences

● Advent Life Sciences founds and invests in early and mid-stage life science companies that
have a first-rate or best-in-class approach to unmet medical needs
● The investment team is made up of experienced professionals, each with extensive scientific experience,
medical and operational experience and a long experience in entrepreneurship e
successful investment in the United States and Europe
● The company invests in a number of areas within the life sciences, including drug discovery, licensing
technologies, digital health and medical technology, with an emphasis on innovation, paradigm-
changing approaches
● Advent Life Sciences is present in the United Kingdom, the United States and France
● For more information, visit

Digiqole announcement

Proximie secures £ 66.75 million investment in Series C led by Advent Life Sciences – UK technology investment news

Source link Proximie secures £ 66.75 million investment in Series C led by Advent Life Sciences – UK technology investment news

Back to top button